Markets are underpricing the threat Warren's democratic socialist policies pose to the health care system.
Major drug makers may pay big to settle opioid-related lawsuits.
In general, Americans have a poor understanding of how a nationalized healthcare plan would work.
Dueling healthcare initiatives from Democrats and the Trump administration pressure insurance stocks.